Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionEquitable Trust Co
Latest Disclosed Ownership21,410 shares
Latest Disclosed Value $ 1,298,516
Equitable Trust Co reports 3.24% increase in ownership of BRM / Bristol-Myers Squibb Company

On April 30, 2026 - Equitable Trust Co filed a 13F-HR form disclosing ownership of 21,410 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,122,312 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 20,738 shares of Bristol-Myers Squibb Company. This represents a change in shares of 3.24% during the quarter. The current value of the position is $1,015,583 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F Bristol-Myers Squibb Com 110122108 21,410 672 3.24 1,299 16.10 0.0353
2026-02-02 2025-12-31 13F Bristol-Myers Squibb Com 110122108 20,738 0 0.00 1,119 19.57 0.0499
2025-11-10 2025-09-30 13F Bristol-Myers Squibb Com 110122108 20,738 -175 -0.84 935 -3.41 0.0430
2025-07-23 2025-06-30 13F Bristol-Myers Squibb Com 110122108 20,913 -177 -0.84 968 -24.73 0.0482
2025-04-25 2025-03-31 13F Bristol-Myers Squibb Com 110122108 21,090 0 0.00 1,286 7.89 0.0713
2025-01-28 2024-12-31 13F Bristol-Myers Squibb Com 110122108 21,090 -800 -3.65 1,193 5.30 0.0666
2024-10-29 2024-09-30 13F Bristol-Myers Squibb Com 110122108 21,890 -2,166 -9.00 1,133 13.31 0.0727
2024-07-31 2024-06-30 13F Bristol Myers Squibb Com 110122108 24,056 355 1.50 999 -22.26 0.0687
2024-04-24 2024-03-31 13F Bristol Myers Squibb Com 110122108 23,701 -6,520 -21.57 1,285 -17.10 0.0891
2024-01-25 2023-12-31 13F Bristol Myers Squibb Com 110122108 30,221 -607 -1.97 1,551 -13.36 0.1166
2023-11-06 2023-09-30 13F Bristol Myers Squibb Com 110122108 30,828 -1,175 -3.67 1,789 -12.56 0.1479
2023-08-08 2023-06-30 13F Bristol Myers Squibb Com 110122108 32,003 0 0.00 2,047 -7.75 0.1565
2023-05-02 2023-03-31 13F Bristol Myers Squibb Com 110122108 32,003 -1,953 -5.75 2,218 -9.21 0.1747
2023-02-17 2022-12-31 13F Bristol Myers Squibb Com 110122108 33,956 -3,308 -8.88 2,443 -7.78 0.1925
2022-10-31 2022-09-30 13F Bristol Myers Squibb Com 110122108 37,264 1,400 3.90 2,649 -4.09 0.2208
2022-07-15 2022-06-30 13F Bristol Myers Squibb Com 110122108 35,864 200 0.56 2,762 6.07 0.2058
2022-05-06 2022-03-31 13F Bristol Myers Squibb Com 110122108 35,664 3,343 10.34 2,604 29.23 0.1673
2022-01-31 2021-12-31 13F Bristol Myers Squibb Com 110122108 32,321 400 1.25 2,015 6.73 0.1245
2021-10-26 2021-09-30 13F Bristol Myers Squibb Com 110122108 31,921 -1,224 -3.69 1,888 -14.76 0.1205
2021-08-03 2021-06-30 13F Bristol Myers Squibb Com 110122108 33,145 -4,725 -12.48 2,215 -7.36 0.1421
2021-05-14 2021-03-31 13F Bristol Myers Squibb Com 110122108 37,870 881 2.38 2,391 4.23 0.1781
2021-02-12 2020-12-31 13F Bristol Myers Squibb Com 110122108 36,989 1,048 2.92 2,294 5.86 0.1703
2020-11-13 2020-09-30 13F Bristol Myers Squibb Com 110122108 35,941 -378 -1.04 2,167 1.45 0.1845
2020-08-18 2020-06-30 13F Bristol Myers Squibb Com 110122108 36,319 1,216 3.46 2,136 9.20 0.1964
2020-05-21 2020-03-31 13F Bristol Myers Squibb Com 110122108 35,103 2,800 8.67 1,956 -5.69 0.2150
2020-02-18 2019-12-31 13F Bristol Myers Squibb Com 110122108 32,303 -2,248 -6.51 2,074 18.38 0.2026
2019-11-19 2019-09-30 13F Bristol Myers Squibb Com 110122108 34,551 -1,755 -4.83 1,752 6.44 0.1846
2019-08-16 2019-06-30 13F Bristol Myers Squibb Com 110122108 36,306 -909 -2.44 1,646 -7.27 0.1747
2019-05-15 2019-03-31 13F Bristol Myers Squibb Com 110122108 37,215 559 1.52 1,775 -6.87 0.2050
2019-02-22 2018-12-31 13F Bristol Myers Squibb Com 110122108 36,656 -2,085 -5.38 1,906 -20.75 0.2522
2018-11-15 2018-09-30 13F Bristol Myers Squibb Com 110122108 38,741 -315 -0.81 2,405 11.24 0.2802
2018-08-14 2018-06-30 13F Bristol Myers Squibb Com 110122108 39,056 39,056 2,162 0.2737
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.